Onyx (ONXX) volatility flat into Kyprolis FDA panel vote

Onyx Pharmaceutical (Nasdaq: ONXX) overall option implied volatility of 50 is near its 26-week average of 53 according to Track Data, suggesting non-directional price movement as shares are halted into a FDA panel vote for Kyprolis.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Carnival Corp. (CCL) call put ratio 3.9 calls to 1 put with a focus on 1600 contracts of October 2 weekly 24 calls into quarter results
• iShares 20+ Year Treasury Bond ETF (TLT) call put ratio 1.7 calls to 1 put
• Western Digital (WDC) call put ratio 1.6 calls to 1 put with a focus on expiring September 25 calls